EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis

Shooka Mohammadi iD, Damoon Ashtary-Larky iD, Mahsa Erfanian-Salim, Navid Alaghemand, Mojtaba Yousefi, Pouyan Sanjari Pirayvatlou, Mohammadreza Mirkarimi, Sara Ayazian Mavi, Ilnaz Alavi iD, Yeganeh Ettehad iD, Milad Mehrbod iD, Omid Asbaghi und 2 weitere

Nutrients · 31.12.2025 · 18 (1) · 134

DOI: 10.3390/nu18010134 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 31.12.2025. Verfasst von Shooka Mohammadi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. Hauptthemen laut MEDLINE: Melatonin, Cardiometabolic Risk Factors, Dietary Supplements, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: There is no definitive consensus regarding the effects of melatonin on cardiometabolic risk factors (CMRFs). This systematic review and dose–response meta-analysis of randomized controlled trials (RCTs) evaluated the impacts of melatonin supplementation on CMRFs, including anthropometric, lipid, glycemic, inflammatory, oxidative, and liver function parameters.

Methods

A systematic search across multiple databases retrieved 63 eligible RCTs published up to October 2025.

Results

This random-effects meta-analysis indicated that melatonin supplementation significantly reduced hip circumference (weighted mean difference (WMD): −1.18 cm, 95% confidence interval (CI): −2.28, −0.08), systolic blood pressure (WMD: −2.34 mmHg, 95% CI: −4.13, −0.55), fasting blood glucose (WMD: −11.63 mg/dL, 95% CI: −19.16, −4.10), low-density lipoprotein cholesterol (WMD: −6.28 mg/dL, 95% CI: −10.53, −2.03), total cholesterol (WMD: −6.97 mg/dL, 95% CI: −12.20, −1.74), C-reactive protein (WMD: −0.59 mg/L, 95% CI: −0.94, −0.23), malondialdehyde (WMD: −1.54 μmol/L, 95% CI: −2.07, −1.01), tumor necrosis factor-alpha (WMD: −1.61 pg/mL, 95% CI: −2.31, −0.90), interleukin-6 (WMD: −6.43 pg/mL, 95% CI: −10.72, −2.15), and alanine aminotransferase (WMD: −2.61 IU/L, 95% CI: −4.87, −0.34). Supplementation with melatonin substantially increased serum total antioxidant capacity (WMD: 0.15 mmol/L, 95% CI: 0.08, 0.22) and high-density lipoprotein cholesterol (WMD: 2.04 mg/dL, 95% CI: 0.50, 3.57). No significant effects of melatonin were observed on body weight, waist circumference, body fat percentage, body mass index, fasting insulin, homeostasis model assessment of insulin resistance, hemoglobin A1c, triglycerides, diastolic blood pressure, aspartate aminotransferase, or gamma-glutamyl transferase.

Conclusions

Melatonin supplementation significantly ameliorated multiple CMRFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninCardiometabolic Risk FactorsDietary SupplementsCardiovascular DiseasesHumansRandomized Controlled Trials as TopicBlood GlucoseBlood PressureDose-Response Relationship, DrugMaleFemaleC-Reactive ProteinMiddle AgedAntioxidants

Stichwörter der Autor:innen

blood pressurecardiometabolic risksglycemic controlinflammationlipid profilemelatoninoxidative stress

Substanzen

MelatoninBlood GlucoseC-Reactive ProteinAntioxidants

Autor:innen und Institutionen

  • Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
  • Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.
  • Department of Pediatric Cardiology, Children's Medical Center, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
  • Department of Cardiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.
  • Department of Internal Medicine, Faculty of Medicine, Alborz University of Medical Sciences, Karaj 3149969415, Iran.
  • Department of Pediatrics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.

ORCID-Profile: Shooka Mohammadi, Damoon Ashtary-Larky, Ilnaz Alavi, Yeganeh Ettehad, Milad Mehrbod, Katsuhiko Suzuki, Russel J Reiter

Zitieren

APA

Mohammadi, S., Ashtary-Larky, D., Erfanian-Salim, M., Alaghemand, N., Yousefi, M., Sanjari Pirayvatlou, P., Mirkarimi, M., Mavi, S. A., Alavi, I., Ettehad, Y., Mehrbod, M., Asbaghi, O., Suzuki, K., & Reiter, R. J. (2025). Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis. Nutrients, 18(1), 134. https://doi.org/10.3390/nu18010134

Vancouver

Mohammadi S, Ashtary-Larky D, Erfanian-Salim M, Alaghemand N, Yousefi M, Sanjari Pirayvatlou P, et al. Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis. Nutrients. 2025;18(1):134. doi:10.3390/nu18010134

BibTeX
@article{Mohammadi2025,
  author = {Mohammadi, Shooka and Ashtary-Larky, Damoon and Erfanian-Salim, Mahsa and Alaghemand, Navid and Yousefi, Mojtaba and Sanjari Pirayvatlou, Pouyan and Mirkarimi, Mohammadreza and Mavi, Sara Ayazian and Alavi, Ilnaz and Ettehad, Yeganeh and Mehrbod, Milad and Asbaghi, Omid and Suzuki, Katsuhiko and Reiter, Russel J},
  title = {Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis},
  journal = {Nutrients},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {134},
  doi = {10.3390/nu18010134}
}
Kostenlos starten →